Releases: monarch-initiative/mondo
Releases · monarch-initiative/mondo
v2024-01-03
Overview:
- Number of new terms: 757
- Number of changed labels: 4
- Number of changed definitions: 2
- Number obsoleted terms: 2
- Number of new obsoletion candidates: 0
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0700224 | PDE6A-related retinopathy | Any retinopathy caused by variants in the PDE6A gene. |
MONDO:0700227 | ELOVL4-related maculopathy | Any maculopathy caused by a variant in the ELOVL4 gene. |
MONDO:0700228 | LRP5-related exudative vitreoretinopathy | Any exudative vitreoretinopathy with or without osteoporosis caused by variants in the LRP5 gene. |
MONDO:0700229 | MAK-related retinopathy | Any retinopathy caused by variants in the MAK gene. |
MONDO:0700230 | GPR143-related foveal hypoplasia | Any foveal hypoplasia with or without albinism caused by a variant in the GPR143 gene. |
MONDO:0700231 | TSPAN12-related exudative vitreoretinopathy | Any exudative vitreoretinopathy caused by variants in the TSPAN12 gene. |
MONDO:0700232 | KIZ-related retinopathy | Any retinopathy caused by variants in the KIZ gene. |
MONDO:0700233 | TOPORS-related retinopathy | Any retinopathy caused by a variant in the TOPORS gene. |
MONDO:0700234 | PRPF8-related retinopathy | Any retinopathy caused by a variant in the PRPF8 gene. |
MONDO:0700235 | RD3-related retinopathy | Any retinopathy caused by variants in the RD3 gene. |
MONDO:0700236 | BBS9-related ciliopathy | Any ciliopathy caused by variants in the BBS9 gene. |
MONDO:0700237 | BBS10-related ciliopathy | Any ciliopathy caused by variants in the BBS10 gene. |
MONDO:0700238 | BEST1-related dominant retinopathy | Any retinopathy caused by a heterozygous variant in the BEST1 gene. |
MONDO:0700239 | BEST1-related recessive retinopathy | Any retinopathy caused by bi-allelic variants in the BEST1 gene. |
MONDO:0700240 | BEST1-related vitreoretinochoroidopathy | Any vitreoretinochoroidopathy caused by a heterozygous variant in the BEST1 gene. |
MONDO:0700241 | IMPG2-related recessive retinopathy | Any retinopathy caused by bi-allelic variants in the IMPG2 gene. |
MONDO:0700242 | IMPG2-related dominant retinopathy | Any retinopathy caused by a heterozygous variant in the IMPG2 gene. |
MONDO:0700243 | CACNA1F-related retinopathy | Any retinopathy caused by a variant in the CACNA1F gene. |
MONDO:0700244 | CACNA2D4-related retinopathy | Any retinopathy caused by variants in the CACNA2D4 gene. |
MONDO:0800456 | SYNCRIP-related neurodevelopmental disorder | Any neurodevelopmental disorder in which the cause of the disease is a variation in the SYNCRIP gene. It is characterized by a neurologic and developmental disorder with autism spectrum disorder (ASD), intellectual disability (ID), and epilepsy. Other signs and symptoms may include cerebral structural anomalies such as periventricular nodular heterotopia and widening of subarachnoid spaces. |
MONDO:0800457 | HNRNPC-related neurodevelopmental disorder | Any neurodevelopmental disorder in which the cause of the disease is a variation in the HNRNPC gene. It is characterized by global developmental delay, intellectual disability, behavioral abnormalities, and subtle facial dysmorphism. It is caused by heterozygous HNRNPC germline variants. |
MONDO:0800458 | NR2F2 related multiple congenital anomalies/dysmorphic syndrome | A heart disease that is present at birth. Representative examples include atrial, ventricular, and atrioventricular septal defects, double-outlet right ventricle, tetralogy of Fallot, hypoplastic left heart syndrome, aortic stenosis, and coarctation of the aorta. |
MONDO:0800460 | ASAH1-related disorders | The spectrum of ASAH1-related disorders ranges from Farber disease (FD) to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). The diagnosis of an ASAH1-related disorder is established in a proband with suggestive clinical findings by identification of biallelic pathogenic variants in ASAH1 and/or decreased activity of the enzyme acid ceramidase in peripheral blood leukocytes or cultured skin fibroblasts. |
MONDO:0800461 | COL4A1-related disorders | The spectrum of COL4A1-related disorders includes small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). |
MONDO:0800462 | FHL1-related myopathy | A group of myopathies that includes Emery-Dreifuss muscular dystrophy (EDMD), and two allelic disorders characterized by the presence of reducing body on histopathology, namely reducing body myopathy (RBM) and scapuloperoneal myopathy. |
MONDO:0800463 | KIF7-related ciliopathy | A spectrum of ciliopathy disorders that typically show autosomal recessive inheritance and includes Al-Gazali-Bakalinova syndrome, hydrolethalus syndrome 2, acrocallosal syndrome, Joubert syndrome 12. |
MONDO:0800464 | SQSTM1-related multisystem proteinopathy | A group of disorders including Paget disease of bone (PBD), inclusion body myopathy (IBM), and less frequently frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Phenotypic presentation and severity are highly variable, and individuals within the same family may present with different associated conditions. |
MONDO:0800465 | CTSC-related disorder | Any ectodermal dysplasia syndrome in which the cause of the disease is a variation in the CTSC gene. Variations in the CTSC gene can result in (1) Papillon-Lefevre syndrome (PLS) characterized by palmoplantar keratoderma, severe periodontitis affecting deciduous and permanent dentitions, and premature loss of dentition, (2) Haim-Munk syndrome (HMS) with additional features of arachnodactly, acroosteolysis, pesplanus, and onychogryphosis, (3) aggressive periodontitis 1 (AP1) characterized by severe and protracted gingival infections, leading to tooth loss. All three phenotypes are associated with autosomal recessive inheritance. |
MONDO:0800466 | disorder of GNAS inactivation | Any endocrine system disorder in which the cause of the disease is inactivation of the GNAS gene. Phenotypes include pseudohypoparathyroidism Ia, Ib, and Ic (PHP-Ia, -Ib, -Ic), pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). |
MONDO:0800467 | dyskeratosis congenita and related telomere biology disorder | A dyskeratosis congenita caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF. |
MONDO:0800468 | SCN4A-related channelopathy | Any muscular channelopathy in which the cause of the disease is a variation in the SCN4 gene. This is characteristic of a continuum in the clinical spectrum that includes sodium-channel myotonia, paramyotonia congenita, hypokalemic periodic paralysis type II and hyperkalemic periodic paralysis. |
MONDO:0800470 | TUBB4A-related neurologic disorder | Any neurologic condition in which the cause of the disease is a mutation in the TUBB4A gene. |
MONDO:0800472 | CYP1B1-related glaucoma with or without anterior segment dysgenesis | Any primary congenital glaucoma in which the cause of the disease is a mutation in the CYP1B1 gene. |
MONDO:0800474 | SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder | An X-linked syndromic intellectual disability caused by alterations to the SOX3 gene which leads to hypopituitarism with variable deficiency of hormones in the anterior lobe of the pituitary gland. In some cases there is also intellectual disability. |
MONDO:0800475 | NACC1-related neurodevelopmental disorder with epilepsy, cataracts and episodic irritability | A neurodevelopmental disorder caused by heterozygous variants in NACC1 and characterized by developmental delay, intellectual disability, epilepsy, cataracts, feeding difficulties, and recurring episodes of extreme irritability. Other phenotypes include hypotonia, delayed myelination, microcephaly, stereotypic hand movements, gastrointestinal tract issues, and sleeping problems. |
MONDO:0800476 | HAND2 related congenital heart defect | A heart disease that is present at birth caused by a variation in th HAND2 gene. Representative examples include tetralogy of fallot and ventricular septal defect. |
MONDO:0800477 | SETD2-related neurodevelopmental disorder without or with macrocephaly/overgrowth | A neurodevelopmental disorder caused by heterozygous variants i... |
v2023-12-12
Overview:
- Number of new terms: 11
- Number of changed labels: 31
- Number of changed definitions: 26
- Number obsoleted terms: 484
- Number of new obsoletion candidates: 20
- Number of terms who were previously candidate for obsoletion and are now not anymore: 6
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100529 | Sunflower syndrome | A rare, photosensitive epileptic disorder characterized by highly stereotyped seizures. During these seizures, individuals with Sunflower syndrome turn toward a bright light while simultaneously waving one hand in front of their eyes. This unique behavior is coupled with abrupt lapses in consciousness. |
MONDO:0100530 | myopathy caused by variation in CRPPA | Any myopathy in which the cause of the disease is a variation in the CRPPA gene. |
MONDO:0100531 | Emery-Dreifuss muscular dystrophy 1, X-linked | |
MONDO:0100532 | blepharospasm, benign essential, susceptibility to | |
MONDO:0800444 | Birt-Hogg-Dube syndrome | |
MONDO:0800445 | Birt-Hogg-Dube syndrome 1 | Any Birt-Hogg-Dube (BHD) syndrome in which the cause of the disease is a variation in the FLCN gene. |
MONDO:0800446 | bleeding diathesis due to thromboxane synthesis deficiency | A rare, genetic, isolated constitutional thrombocytopenia disease characterized by impaired platelet aggregation resulting from a defect in thromboxane synthesis or signaling, manifesting with mild to moderate mucocutaneous, gastrointestinal or surgical bleeding (e.g. easy bruising, prolonged epistaxis, excessive bleeding after a tooth extraction). |
MONDO:0800447 | bleeding disorder, platelet-type, 13, susceptibility to | |
MONDO:0800449 | lysosomal acid lipase deficiency | |
MONDO:0800450 | microcephaly, short stature, and impaired glucose metabolism | |
MONDO:0800455 | Birt-Hogg-Dube syndrome 2 | Birt-Hogg-Dube syndrome caused by the mutations in PRDM10. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0015397 | craniofacial microsomia 1 | oculo-auriculo-vertebral spectrum | craniofacial microsomia 1 |
MONDO:0004759 | zoophilia | bestiality | zoophilia |
MONDO:0007027 | metabolic dysfunction-associated steatohepatitis | non-alcoholic steatohepatitis | metabolic dysfunction-associated steatohepatitis |
MONDO:0013209 | metabolic dysfunction-associated steatotic liver disease | non-alcoholic fatty liver disease | metabolic dysfunction-associated steatotic liver disease |
MONDO:0007078 | pseudohypoparathyroidism type 1A | Pseudohypoparathyroidism type 1A | pseudohypoparathyroidism type 1A |
MONDO:0008451 | neuronopathy, distal hereditary motor, autosomal dominant 1 | neuronopathy, distal hereditary motor, type 1 | neuronopathy, distal hereditary motor, autosomal dominant 1 |
MONDO:0015362 | neuronopathy, distal hereditary motor, autosomal dominant | autosomal dominant distal hereditary motor neuropathy | neuronopathy, distal hereditary motor, autosomal dominant |
MONDO:0010683 | X-linked myotubular myopathy | X-linked centronuclear myopathy | X-linked myotubular myopathy |
MONDO:0010773 | mitochondrial myopathy with diabetes | myopathy and diabetes mellitus | mitochondrial myopathy with diabetes |
MONDO:0010839 | neuronopathy, distal hereditary motor, autosomal dominant 8 | autosomal dominant congenital benign spinal muscular atrophy | neuronopathy, distal hereditary motor, autosomal dominant 8 |
MONDO:0015363 | neuronopathy, distal hereditary motor, autosomal recessive | autosomal recessive distal hereditary motor neuropathy | neuronopathy, distal hereditary motor, autosomal recessive |
MONDO:0011728 | benign essential blepharospasm | blepharospasm | benign essential blepharospasm |
MONDO:0011771 | neuronopathy, distal hereditary motor, autosomal recessive 3 | distal spinal muscular atrophy type 3 | neuronopathy, distal hereditary motor, autosomal recessive 3 |
MONDO:0012190 | epidermolysis bullosa simplex 7, with nephropathy and deafness | nephrotic syndrome - deafness - pretibial epidermolysis bullosa syndrome | epidermolysis bullosa simplex 7, with nephropathy and deafness |
MONDO:0012240 | congenital myopathy 23 | nemaline myopathy 4 | congenital myopathy 23 |
MONDO:0012608 | neuronopathy, distal hereditary motor, autosomal recessive 4 | autosomal recessive lower motor neuron disease with childhood onset | neuronopathy, distal hereditary motor, autosomal recessive 4 |
MONDO:0013772 | Huppke-Brendel syndrome | congenital cataract-hearing loss-severe developmental delay syndrome | Huppke-Brendel syndrome |
MONDO:0013835 | muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 | muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7 | muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 |
MONDO:0013947 | neuronopathy, distal hereditary motor, autosomal recessive 5 | young adult-onset distal hereditary motor neuropathy | neuronopathy, distal hereditary motor, autosomal recessive 5 |
MONDO:0013999 | retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome | optic nerve edema-splenomegaly syndrome | retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome |
MONDO:0014700 | Au-Kline syndrome | neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation | Au-Kline syndrome |
MONDO:0014899 | progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 | adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 |
MONDO:0015007 | spastic paraplegia, intellectual disability, nystagmus, and obesity | spastic paraplegia, intellectual disability, nystagmus, and obesity; | spastic paraplegia, intellectual disability, nystagmus, and obesity |
MONDO:0017939 | classic multiminicore myopathy | minicore myopathy | classic multiminicore myopathy |
MONDO:0020563 | dedifferentiated liposarcoma | Dedifferentiated liposarcoma | dedifferentiated liposarcoma |
MONDO:0030055 | neuronopathy, distal hereditary motor, autosomal recessive 8 | sorbitol dehydrogenase deficiency with peripheral neuropathy | neuronopathy, distal hereditary motor, autosomal recessive 8 |
MONDO:0030977 | neuronopathy, distal hereditary motor, autosomal recessive 7 | neuropathy, hereditary motor, with myopathic features | neuronopathy, distal hereditary motor, autosomal recessive 7 |
MONDO:0100230 | fatty acyl-CoA reductase 1 upregulation | fatty acyl-CoA reductase 1 dysregulation | fatty acyl-CoA reductase 1 upregulation |
MONDO:0800313 | xeroderma pigmentosum, type F/Cockayne syndrome | xeroderma pigmentosum, type F/cockayne syndrome | xeroderma pigmentosum, type F/Cockayne syndrome |
MONDO:0800314 | xeroderma pigmentosum, type G/Cockayne syndrome | xeroderma pigmentosum, type G/cockayne syndrome | xeroderma pigmentosum, type G/Cockayne syndrome |
MONDO:0859300 | neuronopathy, distal hereditary motor, autosomal dominant 10 | Neuronopathy, distal hereditary motor, type X | neuronopathy, distal hereditary motor, autosomal dominant 10 |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0018882 | vasculitis | Vasculitis represents a clinically heterogenous group of diseases of multifactorial etiology characterized by inflammation of either large-sized vessels (large-vessel vasculitis, e.g. Giant-cell arteritis and Takayasu arteritis), medium-sized vessels (medium-vessel vasculitis e.g. polyarteritis nodosa and Kawasaki disease), or small-sized vessels (small-vessel vasculitis, e.g. granulomatosis with polyangiitis, microscopic polyangiitis, immunoglobulin A vasculitis, and cutaneous leukocytoclastic angiitis). Vasculitis occurs at any age, may be acute or chronic, and manifests with general symptoms such as fever, weight loss and fatigue, as well as more specific clinical signs depending on the type of vessels and organs affected. The degree of severity is variable, ranging from life or sight threatening disease (e.g. BehC'et disease) to relatively minor skin disease. | Vasculitis represents a clinically heterogenous group of diseases of multifactorial etiology characterized by inflammation of either large-sized vessels (large-vessel vasculitis, e.g. Giant-cell arteritis and Takayasu arteritis), medium-sized vessels (medium-vessel vasculitis e.g. polyarteritis nodosa and Kawasaki disease), or small-sized vessels (small-vessel vasculitis, e.g. granulomatosis with polyangiitis, microscopic polyangiitis, immunoglobulin A vasculitis, and cutaneous leukocytoclastic angiitis). Vasculitis occurs at any age, may be acute or chronic, and manifests with general symptoms such as fever, weight loss and fatigue, as well as more specific clinical signs depending on the type of vessels and organs affected. The degree of severity is variable, ranging from life or sight threatening disease (e.g. Behcet disease) to relatively minor skin disease. |
MONDO:0007027 | metabolic dysfunction-associated steatohepatitis | Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure. | Metabolic dysfunction-associated steatohepatitis (MASH, formerly known as nonalcoholic steatohepatitis or NASH) is a type of fatty liver disease. It often develops due to a metabolic disorder, such as obesity or diabetes, resulting in a toxic buildup of fat in the liver. It is the most severe form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease or NAFLD). |
MONDO:0013209 | metabolic dysfunction-associated ste... |
v2023-09-12
Overview:
- Number of new terms: 379
- Number of changed labels: 28
- Number of changed definitions: 508
- Number obsoleted terms: 6
- Number of new obsoletion candidates: 236
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100524 | ASAH1-related sphingolipidosis | A spectrum of disorders that includes Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. Both disorders are caused by mutations in the ASAH1 gene that encodes the lysosomal hydrolase that breaks down the bioactive lipid, ceramide. |
MONDO:0100525 | TCF7L2-related neurodevelopmental disorder | A newly discovered disorder caused by a change (variant or mutation) in the TCF7L2 gene. This mutation may be responsible for developmental delays in childhood, intellectual disability, autism, myopia, ADHD, abnormal physical features and other problems. There is a wide spectrum of severity for individuals affected with TRND. Many of the symptoms of TRND overlap with other neurodevelopmental disorders. TRND must be diagnosed with a genetic test and cannot be diagnosed by symptoms alone. |
MONDO:0100526 | breast-ovarian cancer, familial, susceptibility to | |
MONDO:0100527 | dysplastic cortical hyperostosis, Kozlowski-Tsuruta type | An extremely rare primary bone dysplasia with increased bone density characterized by lethal neonatal dwarfism with hydrops, narrow chest and short limbs with extensive cortical thickening of all long bones, ribs, clavicles and scapulae, and coronal clefts in vertebral bodies. |
MONDO:0100528 | Hao-Fountain syndrome due to 16p13.2 microdeletion | A partial deletion of the short arm of chromosome 16 characterized by developmental delay, intellectual disability, speech delay, autism spectrum disorder, epilepsy, hypogonadism, and hypotonia. The behavioral profile includes impulsivity, compulsivity, stubbornness, manipulative behaviors, temper tantrums, and aggressive behaviors. |
MONDO:0800448 | leukoencephalopathy with vanishing white matter | A new leukoencephalopathy, the CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) or VWM (Vanishing White Matter) was identified on clinical and MRI criteria. Classically, this disease is characterized by (1) an onset between 2 and 5 years of age, with a cerebello-spastic syndrome exacerbated by episodes of fever or head trauma leading to death after 5 to 10 years of disease evolution, (2) a diffuse involvement of the white matter on cerebral MRI with a CSF-like signal intensity (cavitation), (3) a recessive autosomal mode of inheritance, (4) neuropathologic findings consistent with a cavitating orthochromatic leukodystrophy with increased number of oligodendrocytes with sometimes \foamy'' aspect." |
MONDO:0957202 | spermatogenic failure, X-linked, 7 | |
MONDO:0957203 | intellectual developmental disorder, X-linked 111 | |
MONDO:0957204 | autoinflammation with pulmonary and cutaneous vasculitis | |
MONDO:0957208 | pituitary hormone deficiency, combined or isolated, 8 | |
MONDO:0957210 | neurooculorenal syndrome | |
MONDO:0957211 | neurodegeneration and seizures due to copper transport defect | |
MONDO:0957215 | congenital myopathy 20 | |
MONDO:0957216 | premature ovarian failure 21 | |
MONDO:0957217 | cortical dysplasia, complex, with other brain malformations 12 | |
MONDO:0957218 | neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities | |
MONDO:0957220 | oocyte/zygote/embryo maturation arrest 17 | |
MONDO:0957221 | spastic paraplegia 70, autosomal recessive | |
MONDO:0957224 | congenital myopathy 21 with early respiratory failure | |
MONDO:0957225 | neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities | |
MONDO:0957228 | intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities | |
MONDO:0957229 | hatipoglu immunodeficiency syndrome | |
MONDO:0957230 | oocyte/zygote/embryo maturation arrest 18 | |
MONDO:0957231 | oocyte/zygote/embryo maturation arrest 19 | |
MONDO:0957240 | cone-rod dystrophy 24 | |
MONDO:0957247 | congenital myopathy 22A, classic | |
MONDO:0957248 | developmental and epileptic encephalopathy 31B | |
MONDO:0957249 | spermatogenic failure 82 | |
MONDO:0957250 | spermatogenic failure 83 | |
MONDO:0957252 | ciliary dyskinesia, primary, 50 | |
MONDO:0957253 | diarrhea 13 | |
MONDO:0957254 | mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A | |
MONDO:0957255 | mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 | |
MONDO:0957260 | combined low LDL and fibrinogen | |
MONDO:0957261 | pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7 | |
MONDO:0957262 | osteopetrosis, autosomal recessive 9 | |
MONDO:0957263 | pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8 | |
MONDO:0957264 | cerebroretinal microangiopathy with calcifications and cysts 3 | |
MONDO:0957265 | congenital myopathy 22B, severe fetal | |
MONDO:0957266 | RECON progeroid syndrome | |
MONDO:0957267 | neurodevelopmental disorder with intracranial hemorrhage, seizures, and spasticity | |
MONDO:0957268 | hypersulfaturia | |
MONDO:0957270 | muscular dystrophy, limb-girdle, autosomal recessive 28 | |
MONDO:0957271 | autoinflammatory disease, systemic, with vasculitis | |
MONDO:0957273 | Charcot-Marie-Tooth disease, dominant intermediate A | |
MONDO:0957274 | spastic paraplegia 89, autosomal recessive | |
MONDO:0957278 | oocyte/zygote/embryo maturation arrest 20 | |
MONDO:0957279 | auditory neuropathy, autosomal dominant 2 | |
MONDO:0957281 | nemaline myopathy 5B, autosomal recessive, childhood-onset | |
MONDO:0957284 | nemaline myopathy 5C, autosomal dominant | |
MONDO:0957288 | intellectual developmental disorder, autosomal recessive 79 | |
MONDO:0957294 | pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9 | |
MONDO:0957301 | spermatogenic failure 84 | |
MONDO:0957303 | palmoplantar keratoderma, epidermolytic, 2 | |
MONDO:0957307 | woolly hair-skin fragility syndrome | |
MONDO:0957308 | spastic paraplegia 90A, autosomal dominant | |
MONDO:0957309 | spastic paraplegia 90B, autosomal recessive | |
MONDO:0957314 | retinitis pigmentosa 97 | |
MONDO:0957337 | isolated chorioretinal dystrophy | |
MONDO:0957341 | secondary early-onset glaucoma | |
MONDO:0957382 | multiple mitochondrial dysfunctions syndrome 7 | |
MONDO:0957385 | dystonia 37, early-onset, with striatal lesions | |
MONDO:0957386 | neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities | |
MONDO:0957388 | autoimmune disease, multisystem, infantile-onset, 3 | |
MONDO:0957396 | ciliary dyskinesia, primary, 51 | |
MONDO:0957397 | intellectual developmental disorder, autosomal dominant 72 | |
MONDO:0957403 | periodic fever syndrome of childhood | |
MONDO:0957404 | pyogenic autoinflammatory syndrome of childhood | |
MONDO:0957405 | granulomatous autoinflammatory syndrome of childhood | |
MONDO:0957408 | type 1 interferonopathy of childhood | |
MONDO:0957421 | borna virus encephalitis | |
MONDO:0957423 | immunotherapy induced hypophysitis | |
MONDO:0957426 | autosomal recessive hyper-IgE syndrome | |
MONDO:0957427 | B-lymphoblastic leukemia/lymphoma with t(7;9)(q11.2;p13.2) | |
MONDO:0957428 | B-lymphoblastic leukemia/lymphoma with t(17;19) | |
MONDO:0957430 | childhood-onset schizophrenia | |
MONDO:0957431 | endogenous Cushing syndrome | |
MONDO:0957432 | neonatal compartment syndrome | |
MONDO:0957433 | primary pulmonary vein stenosis | |
MONDO:0957442 | autosomal recessive ataxia due to PEX16 deficiency | |
MONDO:0957443 | autosomal recessive ataxia due to PEX2 deficiency | |
MONDO:0957451 | non-terminal myelocystocele | A rare closed spinal dysraphism characterized by myelocystocele located above the conus region. Also considered as a form of saccular limited dorsal myeloschisis. |
MONDO:0957452 | segmental arterial mediolysis | |
MONDO:0957453 | true myelomeningocele | A rare open neural tube defect characterized by no other malformation than myelomeningocele (spina bifida with a neural placode exposed at the top of a non-epidermised dysplasic meninges sac and Chiari II malformation). |
MONDO:0957454 | hemi-myelomeningocele | A very rare form of composite dysraphism characterized by the presence of a split cord malformation and a myelomeningocele on one of the two hemicords. Hemicords can be in a single dural sac or in two separated dural sacs. Other spinal cord malformations can be associated. Due to the comparable prognosis it is considered as a subtype of myelomeningocele. |
MONDO:0957456 | classical dermatomyositis | |
MONDO:0957458 | adermatopathic dermatomyositis | |
MONDO:0957459 | congenital esophageal stenosis | |
MONDO:0957460 | spontaneous intestinal perforation | |
MONDO:0957461 | primary tuberculous lymphadenitis | |
MONDO:0957462 | primary pulmonary tuberculosis | |
MONDO:0957463 | primary bone and joint tuberculosis | |
MONDO:0957464 | primary cutaneous tuberculosis | |
MONDO:0957465 | multifocal tuberculosis | |
MONDO:0957466 | primary tuberculosis of the digestive system | |
MONDO:0957467 | primary genito-urinary tuberculosis | |
MONDO:0957473 | craniosynostosis-facial dysmorphism-chiari-1 malformation-developmental and language delay syndrome | |
MONDO:0957476 | isolated persistent urogenital sinus | |
MONDO:0957477 | MYT1L-related developmental delay-intellectual disability-obesity syndrome | |
MONDO:0957481 | idiopathic pregnancy-associated osteoporosis | |
MONDO:0957487 | idiopathic cat... |
v2023-08-02
Overview:
- Number of new terms: 1
- Number of changed labels: 3
- Number of changed definitions: 18
- Number obsoleted terms: 10
- Number of new obsoletion candidates: 230
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:1010000 | pythiosis | A granulomatous disease caused by the aquatic organism pythium insidiosum occurring rarely in humans. It is classified into three forms: ocular, cutaneous, and arterial. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0007062 | adactylia, unilateral | congenital absence/hypoplasia of fingers excluding thumb, unilateral | adactylia, unilateral |
MONDO:0008409 | congenital myopathy 7A, myosin storage, autosomal dominant | MYH7-related late-onset scapuloperoneal muscular dystrophy | congenital myopathy 7A, myosin storage, autosomal dominant |
MONDO:0044635 | DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome | diaph1-related sensorineural hearing loss-thrombocytopenia syndrome | DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0002113 | peritoneal carcinoma | A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary. Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively. The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement. | A peritoneum cancer that is located in the inside of the abdomen. |
MONDO:0015686 | primary peritoneal carcinoma | Primary peritoneal carcinoma (PPC) is a rare malignant tumor of the peritoneal cavity of extra-ovarian origin, clinically and histologically similar to advanced-stage serous ovarian carcinoma. | A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary. Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively. The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement. |
MONDO:0007062 | adactylia, unilateral | Unilateral adactylia is a terminal transverse defect of the hand characterized by the absence of the terminal portions of digits 2 to 5 with a hypoplastic thumb (adactylia). | A rare, non-syndromic, terminal transverse limb reduction defect characterized by unilateral absence of the terminal portions of digits 2 to 5, with a mildly hypoplastic thumb and small nail remnants on the digital stumps. Metacarpal bones may be variably reduced. |
MONDO:0008346 | pulmonary hemosiderosis | Idiopathic pulmonary hemosiderosis is a respiratory disease due to repeated episodes of diffuse alveolar hemorrhage without any underlying apparent cause, most often in children. Anemia, cough, and pulmonary infiltrates on chest radiographs are found in majority of the patients. | A respiratory disease due to repeated episodes of diffuse alveolar hemorrhage without any underlying apparent cause, most often in children. Anemia, cough, and pulmonary infiltrates on chest radiographs are found in majority of the patients. |
MONDO:0008458 | spinocerebellar ataxia type 2 | Spinocerebellar ataxia type 2 (SCA2) is a subtype of type I autosomal dominant cerebellar ataxia (ADCA type I) characterized by truncal ataxia, dysarthria, slowed saccades and less commonly ophthalmoparesis and chorea. | A subtype of type I autosomal dominant cerebellar ataxia (ADCA type I) characterized by truncal ataxia, dysarthria, slowed saccades and less commonly ophthalmoparesis and chorea. |
MONDO:0008675 | Freeman-Sheldon syndrome | Freeman-Sheldon syndrome (FSS) is a very rare, multiple congenital contractures syndrome characterized by a microstomia with a whistling appearance of the mouth, distinctive facies, club foot and joint contractures. FSS is the most severe form of distal arthrogryposis. | A very rare, multiple congenital contractures syndrome characterized by a microstomia with a whistling appearance of the mouth, distinctive facies, club foot and joint contractures. FSS is the most severe form of distal arthrogryposis. |
MONDO:0008843 | atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome | Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome is characterised by sensorineural deafness, diabetes mellitus, progressive neurological deterioration with photomyoclonic epilepsy, and progressive nephropathy. It has been described in two brothers. Premature atherosclerosis of renal, coronary, and cerebral arteries and the aorta was also observed. | A rare, severe, circulatory system disease characterized by premature, diffuse, severe atherosclerosis (including the aorta and renal, coronary, and cerebral arteries), sensorineural deafness, diabetes mellitus, progressive neurological deterioration with cerebellar symptoms and photomyoclonic seizures, and progressive nephropathy. Partial deficiency of mitochondrial complexes III and IV in the kidney and fibroblasts (but not in muscle) may be associated. There have been no further descriptions in the literature since 1994. |
MONDO:0009835 | subacute sclerosing panencephalitis | Subacute sclerosing panencephalitis (SSPE) is a chronic progressive encephalitis that develops a few years after measles infection and presents with a demyelination of the cerebral cortex. | A chronic progressive encephalitis that develops a few years after measles infection and presents with a demyelination of the cerebral cortex. |
MONDO:0011191 | capillary infantile hemangioma | Capillary hemangiomas are benign, highly proliferative lesions involving aberrant localized growth of capillary endothelium. They are the most common tumor of infancy, occurring in up to 10% of all births. Hemangiomas tend to appear shortly after birth and show rapid neonatal growth for up to 12 months characterized by endothelial hypercellularity and increased numbers of mast cells. This phase is followed by slow involution at a rate of about 10% per year and replacement by fibrofatty stroma. Hemangiomas are classified as distinct from vascular malformations, in that the latter are present from birth, tend to grow with the individual, do not regress, and show normal rates of endothelial cell turnover. Most hemangiomas occur sporadically, but some families with autosomal dominant inheritance have been reported. | Capillary hemangiomas are benign, highly proliferative lesions involving aberrant localized growth of capillary endothelium. They are the most common tumor of infancy, occurring in up to 10% of all births. Hemangiomas tend to appear shortly after birth and show rapid neonatal growth for up to 12 months characterized by endothelial hypercellularity and increased numbers of mast cells. This phase is followed by slow involution at a rate of about 10% per year and replacement by fibrofatty stroma. Hemangiomas are classified as distinct from vascular malformations, in that the latter are present from birth, tend to grow with the individual, do not regress, and show normal rates of endothelial cell turnover. |
MONDO:0013646 | chromosome 8q21.11 deletion syndrome | 8q21.11 microdeletion syndrome encompasses heterozygous overlapping microdeletions on chromosome 8q21.11 resulting in intellectual disability, facial dysmorphism comprising a round face, ptosis, short philtrum, Cupid's bow and prominent low-set ears, nasal speech and mild finger and toe anomalies. | Heterozygous overlapping microdeletions on chromosome 8q21.11 resulting in intellectual disability, facial dysmorphism comprising a round face, ptosis, short philtrum, Cupid's bow and prominent low-set ears, nasal speech and mild finger and toe anomalies. |
MONDO:0014165 | multiple congenital anomalies-hypotonia-seizures syndrome 3 | Intellectual disability-seizures-hypotonia-ophthalmologic-skeletal anomalies syndrome is a rare congenital disorder of glycosylation characterized by neonatal hypotonia, global development delay, developmental regress and severe to profound intellectual disability, infantile onset seizures that are initially associated with febrile episodes with subsequent transition to unprovoked seizures, impaired vision with esotropia and nystagmus, progressive cerebral and cerebellar atrophy, skeletal abnormalities (including brachycephaly, scoliosis, slender long bones, delayed bone age, pectus excavatum and osteopenia), inverted nipples and dysmorphic features including high and narrow forehead, frontal bossing, short nose, depressed nasal bridge, anteverted nares, high palate and wide open mouth consistent with facial hypotonia. Other features may include cardiac abnormalities (such as patent ductus arteriosus, atrial septal defects), urogenital abnormalities (such as nephrocalcinosis, urolithiasis), and low plasma concentration of alkaline phosphatase. | A rare congenital disorder of glycosylation characterized by neonatal hypotonia, global development delay, developmental regress and severe to profound intellectual disability, infantile onset seizures that are initially associated with febrile episodes with subsequent transition to unprovoked seizures, impaired vision with esotropia and nystagmus, progressive cerebral and cerebellar atrophy, skeletal abnormaliti... |
v2023-07-03
Overview:
- Number of new terms: 82
- Number of changed labels: 50
- Number of changed definitions: 24
- Number obsoleted terms: 24
- Number of new obsoletion candidates: 20
- Number of terms who were previously candidate for obsoletion and are now not anymore: 10
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100513 | TRAF3 haploinsufficiency | Any Mendelian disease in which the cause of the disease is a mutation in the TRAF3 gene. TRAF3 haploinsufficiency caused by heterozygous loss of function (null) variants presents as an immune dysregulation syndrome of recurrent bacterial infections, autoimmunity, systemic inflammation, B cell lymphoproliferation, and hypergammaglobulinemia. |
MONDO:0100519 | epilepsy, idiopathic generalized, susceptibility to, 17 | |
MONDO:0100520 | NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction | The NKX2-1 gene is located on chromosome 14 at 14q13.3 and encodes the NK2 homeobox 1 protein, a transcription factor that binds and activates thyroid specific genes. NKX2-1 was first reported in relation to autosomal dominant NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction in 1998. |
MONDO:0100521 | NOG-related symphalangism spectrum disorder | An autosomal dominant condition caused by pathogenic variants of the NOG gene, encoding the noggin protein. Five overlapping clinical syndromes associated with NOG mutations have been described; proximal symphalangism, multiple synostoses syndrome 1, tarsal-carpal coalition syndrome, stapes ankylosis with broad thumbs and toes, and brachydactyly type B2. NOG-related symphalangism spectrum disorder is a new term initially proposed by Potti et al., 2011 to encompass these disorders. NOG-SSD is characterized by proximal symphalangism, conductive deafness caused by stapes ankylosis, ocular abnormality such as hyperopia and strabismus, and characteristic facial features including a broad, tubular-shaped nose and a thin upper vermilion. |
MONDO:0100522 | hypotrichosis 4 | |
MONDO:0100523 | SPAST-related motor disorder | Heterozygous variants in SPAST have been reported in relation to pure spastic paraplegias (infantile, ascending), complicated or complex spastic paraplegia (with dementia, cerebellar ataxia, epilepsy, and/or peripheral neuropathy) and cerebral palsy. Age of symptom onset ranges from neonatal to advanced age with varying symptom severity, |
MONDO:0957001 | hereditary mixed dermis disorder | |
MONDO:0957003 | hereditary neuro-ophthalmological disease | |
MONDO:0957008 | hereditary cerebral malformation | |
MONDO:0957009 | hereditary posterior fossa malformation | |
MONDO:0957018 | autoinflammatory syndrome of childhood | |
MONDO:0957024 | hereditary 46,XX disorder of sex development | |
MONDO:0957025 | hereditary 46,XY disorder of sex development | |
MONDO:0957048 | isolated macular dystrophy | |
MONDO:0957097 | hereditary hemolytic uremic syndrome | |
MONDO:0957111 | neurological muscular channelopathy due to a genetic sodium channel defect | |
MONDO:0957112 | neurological muscular channelopathy due to a genetic chloride channel defect | |
MONDO:0957113 | neurological muscular channelopathy due to a genetic calcium channel defect | |
MONDO:0957114 | neurological muscular channelopathy due to a genetic potassium channel defect | |
MONDO:0957115 | neurological muscular channelopathy due to a genetic ryanodine receptor defect | |
MONDO:1011300 | acute disease, non-human animal | Acute disease that occurs in non-human animals. |
MONDO:1011301 | auditory system disorder, non-human animal | Auditory system disorder that occurs in non-human animals. |
MONDO:1011302 | branchial arch disease, non-human animal | Branchial arch disease that occurs in non-human animals. |
MONDO:1011303 | mammary gland disorder, non-human animal | Mammary gland disorder that occurs in non-human animals. |
MONDO:1011304 | mammary fibrocystic disease, non-human animal | Mammary fibrocystic disease that occurs in non-human animals. |
MONDO:1011305 | cancer or benign tumor, non-human animal | Cancer or benign tumor that occurs in non-human animals. |
MONDO:1011306 | cardiovascular disorder, non-human animal | Cardiovascular disorder that occurs in non-human animals. |
MONDO:1011307 | chromosomal disorder, non-human animal | Chromosomal disorder that occurs in non-human animals. |
MONDO:1011308 | congenital nervous system disorder, non-human animal | Congenital nervous system disorder that occurs in non-human animals. |
MONDO:1011309 | connective tissue disorder, non-human animal | Connective tissue disorder that occurs in non-human animals. |
MONDO:1011310 | developmental defect during embryogenesis, non-human animal | Developmental defect during embryogenesis that occurs in non-human animals. |
MONDO:1011311 | digestive system disorder, non-human animal | Digestive system disorder that occurs in non-human animals. |
MONDO:1011312 | disease related to transplantation, non-human animal | Disease related to transplantation that occurs in non-human animals. |
MONDO:1011313 | disorder of development or morphogenesis, non-human animal | Disorder of development or morphogenesis that occurs in non-human animals. |
MONDO:1011314 | disorder of glycosylation, non-human animal | Disorder of glycosylation that occurs in non-human animals. |
MONDO:1011315 | disorder of orbital region, non-human animal | Disorder of orbital region that occurs in non-human animals. |
MONDO:1011316 | disorder of visual system, non-human animal | Disorder of visual system that occurs in non-human animals. |
MONDO:1011317 | endocrine system disorder, non-human animal | Endocrine system disorder that occurs in non-human animals. |
MONDO:1011318 | hearing disorder, non-human animal | Hearing disorder that occurs in non-human animals. |
MONDO:1011319 | hematologic disorder, non-human animal | Hematologic disorder that occurs in non-human animals. |
MONDO:1011321 | hereditary disease, non-human animal | Hereditary disease that occurs in non-human animals. |
MONDO:1011322 | iatrogenic disease, non-human animal | Iatrogenic disease that occurs in non-human animals. |
MONDO:1011323 | idiopathic disease, non-human animal | Idiopathic disease that occurs in non-human animals. |
MONDO:1011325 | immunodeficiency-related disorder, non-human animal | Immunodeficiency-Related disorder that occurs in non-human animals. |
MONDO:1011327 | inflammatory disease, non-human animal | Inflammatory disease that occurs in non-human animals. |
MONDO:1011328 | integumentary system disorder, non-human animal | Integumentary system disorder that occurs in non-human animals. |
MONDO:1011329 | keratoconjunctivitis, non-human animal | Keratoconjunctivitis that occurs in non-human animals. |
MONDO:1011330 | lymphoid system disorder, non-human animal | Lymphoid system disorder that occurs in non-human animals. |
MONDO:1011331 | metabolic disease, non-human animal | Metabolic disease that occurs in non-human animals. |
MONDO:1011332 | mitochondrial disease, non-human animal | Mitochondrial disease that occurs in non-human animals. |
MONDO:1011333 | mouth disorder, non-human animal | Mouth disorder that occurs in non-human animals. |
MONDO:1011334 | mouth mucosa disorder, non-human animal | Mouth mucosa disorder that occurs in non-human animals. |
MONDO:1011335 | musculoskeletal system disorder, non-human animal | Musculoskeletal system disorder that occurs in non-human animals. |
MONDO:1011336 | nervous system disorder, non-human animal | Nervous system disorder that occurs in non-human animals. |
MONDO:1011337 | neurocristopathy, non-human animal | Neurocristopathy that occurs in non-human animals. |
MONDO:1011338 | nutritional disorder, non-human animal | Nutritional disorder that occurs in non-human animals. |
MONDO:1011339 | obstetric disorder, non-human animal | Obstetric disorder that occurs in non-human animals. |
MONDO:1011340 | occupational disorder, non-human animal | Occupational disorder that occurs in non-human animals. |
MONDO:1011341 | omphalitis, non-human animal | Omphalitis that occurs in non-human animals. |
MONDO:1011342 | otorhinolaryngologic disease, non-human animal | Otorhinolaryngologic disease that occurs in non-human animals. |
MONDO:1011343 | perceptual disorders, non-human animal | Perceptual disorders that occurs in non-human animals. |
MONDO:1011344 | perinatal disease, non-human animal | Perinatal disease that occurs in non-human animals. |
MONDO:1011345 | poisoning, non-human animal | Poisoning that occurs in non-human animals. |
MONDO:1011346 | post-bacterial disorder, non-human animal | Post-Bacterial disorder that occurs in non-human animals. |
MONDO:1011347 | post-COVID-19 disorder, non-human animal | Post-Covid-19 disorder that occurs in non-human animals. |
MONDO:1011348 | post-infectious disorder, non-human animal | Post-Infectious disorder that occurs in non-human animals. |
MONDO:1011349 | post-viral disorder, non-human animal | Post-Viral disorder that occurs in non-human animals. |
MONDO:1011350 | premature aging syndrome, non-human animal | Premature aging syndrome that occurs in non-human animals. |
MONDO:1011351 | psychiatric disorder, non-human animal | Psychiatric disorder that occurs in non-human animals. |
MONDO:1011352 | radiation-induced disorder, non-human animal | Radiation-induced disorder that occurs in non-human animals. |
MONDO:1011353 | radiculitis, non-human animal | Radiculitis that occurs in non-human animals. |
MONDO:1011354 | reproductive system disorder, non-human animal | Reproductive system disorder that occurs in non-human animals. |
MONDO:1011356 | sensory ganglionopathy, non-human animal | Sensory ganglionopathy... |
v2023-06-01
Overview:
- Number of new terms: 106
- Number of changed labels: 6
- Number of changed definitions: 6
- Number obsoleted terms: 5
- Number of new obsoletion candidates: 14
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100351 | POLD1-related polyposis and colorectal cancer syndrome | An autosomal dominant hereditary syndrome caused by germline pathogenic POLD1 variants. It is characterized by the presence of colorectal polyps and colorectal cancer. |
MONDO:0100472 | lissencephaly spectrum disorder with complex brainstem malformation | A lissencephaly spectrum disorder that manifests as posterior predominant pachygyria (ranging from mild severity to classic lissencephaly) and brainstem malformations which include brainstem dysplasia (typically with reduced anteroposterior thickness and transverse broadening of the pons/medulla) and midline crossing defects (anterior commissure, transverse pontine fibers, pyramidal tract, callosum hypoplasia). |
MONDO:0100499 | multiple congenital anomalies due to 14q32.2 imprinting defect | Multiple congenital anomalies caused by imprinting defects at 14q32.2 include Kagami-Ogata syndrome and Temple syndrome. Kagami-Ogata syndrome is characterized by typical facial features, skeletal abnormalities (including \coat-hanger ribs", and bell-shaped thorax), abdominal wall defects, and developmental delay, and is caused by defects or absence of maternally derived imprinting signals (including paternal UPD14). Temple syndrome is a less specific phenotype including intrauterine and postnatal growth restriction, hypotonia, feeding difficulties in infancy, truncal obesity, and small feet and hands. Temple syndrome is caused by defects or absence of paternally derived imprinting signals (including maternal UPD14)." |
MONDO:0100507 | multiple congenital anomalies due to 14q32.2 paternally expressed gene defect | Temple syndrome is a less specific phenotype including intrauterine and postnatal growth restriction, hypotonia, feeding difficulties in infancy, truncal obesity, and small feet and hands. Temple syndrome is caused by defects or absence of paternally derived imprinting signals (including maternal UPD14). |
MONDO:0100508 | salivary gland type cancer of the breast | A group of uncommon neoplasms, usually seen in the salivary glands but occurring in the breast, with a variable clinicopathologic spectrum and divided into those with myoepithelial differentiation and those without. This group includes mammary adenoid cystic carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, acinic cell carcinoma, polymorphous low-grade adenocarcinoma and oncocytic carcinoma. |
MONDO:0100512 | mitochondrial DNA depletion syndrome, hepatocerebral form | |
MONDO:0800439 | syndromic complex neurodevelopmental disorder | A disorder that involves more than one phenotype associated with the central nervous system, including but not limited to intellectual disability, autism, and seizures (epilepsy), and also a distinctive pattern of other features including dysmorphisms and/or congenital malformations. |
MONDO:0800440 | HAND1 related congenital heart defect | A heart disease that is present at birth caused by a variation in HAND1. Representative examples include ventricular septal defect, tetralogy of Fallot, and double outlet right ventricle. |
MONDO:0800441 | NKX2.5-related congenital, conduction and myopathic heart disease | A heart disease that includes congenital heart defects, abnormal cardiac conduction or myopathy. Congenital heart defects consists of any heart disease that is present at birth. Representative examples include atrial septal defect, ventricular septal defect, tetralogy of Fallot, and hypoplastic left heart syndrome. |
MONDO:0800442 | MYH-6 related congenital heart defects | A heart disease that is present at birth that is caused by a variation in MYH-6. Representative examples include atrial septal defect, ventricular septal defect, tetralogy of Fallot and hypoplastic left heart syndrome. |
MONDO:0800443 | DEAF1-associated neurodevelopmental disorder | A neurodevelopmental disorder characterized predominantly by intellectual disability, speech delay, motor delay, autism, sleep disturbances, and a high pain threshold. This disorder may be inherited in an autosomal dominant or autosomal recessive manner, likely due to mono-allelic variant resulting in altered function and bi-allelic variants resulting in loss of function, respectively. |
MONDO:0850094 | drug-induced hearing loss | |
MONDO:0850098 | oligoasthenoteratozoospermia | |
MONDO:0850122 | solid adenocarcinoma with mucin production | |
MONDO:0850123 | autonomic nervous system benign neoplasm | |
MONDO:0850126 | testicular sex cord-stromal benign neoplasm | A sex cord-stromal benign neoplasm that arises from the testis. |
MONDO:0850127 | epithelioid inflammatory myofibroblastic sarcoma | |
MONDO:0850144 | germ cell benign neoplasm | A benign neoplasm that derives from germ cells. |
MONDO:0850150 | kidney cortex disease | A kidney disease that is located in the kidney cortex. |
MONDO:0850170 | spinal muscular atrophy type 0 | A childhood spinal muscular atrophy that is evident before birth and characterized by diminished movement in the womb, joint deformities, extremely weak muscle tone and very weak respiratory muscles. |
MONDO:0850196 | medulloblastoma WNT activated | A medulloblastoma that is characterized as a molecular subtype by activation of the WNT pathway and TP53 mutations may be present or absent. |
MONDO:0850197 | medulloblastoma SHH activated | A medulloblastoma that is characterized as a molecular subtype by activation of the sonic hedgehog (SHH) pathway and TP53 mutations that may be present or absent. |
MONDO:0850198 | medulloblastoma non-WNT/non-SHH | A medulloblastoma that is characterized as a molecular subtype that is not associated with activation of the WNT pathway or sonic hedgehog (SHH) pathway and TP53 mutations are absent. |
MONDO:0850225 | autoimmune cholangitis | An autoimmune hepatitis that is characterized by primary biliary cirrhosis clinical, biochemical, and histologic characteristics with antinuclear antibody positive sera. |
MONDO:0850230 | chronic urticaria | An urticaria that is characterized by the presence of urticaria for a period exceeding 6 weeks, assuming symptoms for most days of the week. |
MONDO:0850231 | erythema nodosum | A panniculitis that is characterized by sudden onset of painful, erythematous, subcutaneous nodules mainly localized to the pretibial areas. Lesions are usually bilateral and symmetrical, ranging from 1 to 5 cm in diameter. |
MONDO:0850257 | mucinous pancreas adenocarcinoma | A pancreatic adenocarcinoma that derives from epithelial cells originating in glandular tissue, which produce mucin. |
MONDO:0850267 | childhood acute megakaryoblastic leukemia | An acute megakaryocytic leukemia that is characterized by fusion oncogenes involving transcriptional regulators in childhood. |
MONDO:0850269 | core binding factor acute myeloid leukemia | An acute myeloid leukemia that is characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities result in disruption of the transcription factor CBF, which is a regulator of normal hematopoiesis. |
MONDO:0850271 | myeloid leukemia associated with down syndrome | An acute megakaryocytic leukemia occurring in children with Down syndrome and that has material basis in mutation in the GATA1 gene. |
MONDO:0850282 | chronic asthma | An asthma that is characterized by the development of persistent airway inflammation and recurrent attacks of breathlessness and wheezing, which vary in severity and frequency. |
MONDO:0850283 | acute asthma | An asthma that is characterized by severe and sudden onset of increasing wheezing, airways closing, smooth muscle contraction, mucus plugging and lower airway edema that may be reversible upon treatment. |
MONDO:0850284 | extrinsic asthma | A chronic asthma that is triggered by an allergen and that is characterized by an immune system overreaction to a harmless substance, such as pollen or dust, with the subsequent release of immunoglobin E (IgE) antibodies. |
MONDO:0850285 | environmental induced asthma | An intrinsic asthma that is characterized by exposure to tobacco smoke and other inflammatory gases or particulate matter. |
MONDO:0850286 | exercise-induced bronchoconstriction | An intrinsic asthma that is characterized by narrowing of the airways during or shortly after exercise. |
MONDO:0850287 | aspirin-induced respiratory disease | An intrinsic asthma that is characertized by severe and prolonged airway obstruction after the ingestion of aspirin or other non-steroidal anti-inflammatory drugs. |
MONDO:0850289 | human betaherpesvirus 5 infectious disease | A disease caused by infection with Human betaherpesvirus 5. |
MONDO:0850301 | pemphigoid | An autoimmune disease of skin and connective tissue that is characterized by subepidermal blistering especially in the lower abdomen, groin, and flexor surfaces of the extremities, creating tense blisters that do not break easily. |
MONDO:0850302 | intracranial meningioma | A meningioma that arises within the cranial cavity. |
MONDO:0850303 | supratentorial meningioma | A meningioma that affects the supratentorial brain. |
MONDO:0850306 | latent autoimmune diabetes in adults | A type 1 diabetes mellitus that is characterized by a less intensive autoimmune process, highly variable β-cell destruction, different degrees of insulin resistance and heterogeneous titre and pattern of islet autoantibody, sharing features with both type 1 and type 2 diabetes mellitus. |
MONDO:0850312 | anaplastic pleomorphic xanthoastrocytoma | A malignant astr... |
v2023-05-01
Overview:
- Number of new terms: 86
- Number of changed labels: 21
- Number of changed definitions: 42
- Number obsoleted terms: 9
- Number of new obsoletion candidates: 5
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100313 | focal segmental glomerulosclerosis | A renal disorder characterized by sclerotic lesions in the glomeruli. Causes include drugs, viruses, and malignancies (lymphomas), or it may be idiopathic. It presents with asymptomatic proteinuria or nephritic syndrome and it may lead to renal failure. |
MONDO:0100314 | GYG1-related disorder of glycogen metabolism | Any disorder of glycogen metabolism in which the cause of disease is a mutation in the GYG1 gene. |
MONDO:0100317 | deficiency of adenosine deaminase 2 | Any disease or disorder in which the cause of the disease is a mutation in the ADA2 gene. |
MONDO:0100323 | inherited pseudohypoaldosteronism | A form of pseudohypoaldosteronism that is characterized Mendelian (autosomal dominant, recessive, or X-linked) or chromosomal etiology. |
MONDO:0100324 | primary focal segmental glomerulosclerosis | A form of focal segmental glomerulosclerosis without identifiable etiology. Primary (idiopathic) FSGS has been associated with the presence of circulating permeability factors/cytokines, which cause foot process effacement and proteinuria. |
MONDO:0100331 | nerve agent poisoning | A poisoning that is caused by exposure to a nerve agent or gas. |
MONDO:0100335 | local anesthetic poisoning | A poisoning that is caused by exposure to a local anesthetic. |
MONDO:0100341 | fire ant poisoning | A poisoning that is caused by exposure to a fire ant bite or sting. Fire ants tend to be an aggressive insect that will sting causing very painful reactions. There are two types of fire ants which belong to the Solenopsis species. |
MONDO:0100346 | microcephaly with or without short stature | Primary microcephaly refers to the clinical finding of a head circumference more than than 3 standard deviations (SD) below the age- and sex-related mean, present at birth. Primary microcephaly is a static developmental anomaly, distinguished from secondary microcephaly, which refers to a progressive neurodegenerative condition. Microcephaly is a disorder of fetal brain growth; individuals with microcephaly have small brains and almost always have intellectual disability, although rare individuals with mild microcephaly (-3 SD) and normal intelligence have been reported. Additional clinical features may include short stature or mild seizures. These clinical features include Seckel syndrome, a rare autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly with intellectual disability. |
MONDO:0850007 | syndromic lacrimal system disorder | |
MONDO:0858986 | autosomal dominant spastic paraplegia type 80 | |
MONDO:0858987 | autosomal recessive spastic paraplegia type 82 | |
MONDO:0858988 | autosomal recessive spastic paraplegia type 83 | |
MONDO:0858989 | autosomal recessive spastic paraplegia type 84 | |
MONDO:0858990 | autosomal recessive spastic paraplegia type 85 | |
MONDO:0858991 | autosomal recessive spastic paraplegia type 86 | |
MONDO:0858992 | autosomal recessive spastic paraplegia type 87 | |
MONDO:0858997 | cancer of unknown primary site | |
MONDO:0858998 | mesomelic dysplasia-digital anomalies-intellectual disability syndrome | |
MONDO:0858999 | KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome | |
MONDO:0859000 | SLC12A2-related developmental delay-intellectual disability-sensorineural deafness syndrome | |
MONDO:0859001 | CPE-related Prader-Willi-like syndrome | |
MONDO:0859002 | intellectual disability-early-onset cataract-microcephaly syndrome | |
MONDO:0859003 | PAICS deficiency | |
MONDO:0859004 | invasive scopulariopsis infection | |
MONDO:0859005 | preaxial digit brachydactyly-webbed fingers | |
MONDO:0859006 | proximal femoral focal deficiency | |
MONDO:0859007 | mosaic Legius syndrome | |
MONDO:0859008 | neurofibromatosis/schwannomatosis | |
MONDO:0859050 | Schistosoma mansoni infection, susceptibility/resistance to | |
MONDO:0859082 | thrombophilia, X-linked, due to factor 8 defect | |
MONDO:0859149 | hypertriglyceridemia 2 | |
MONDO:0859151 | fibromuscular dysplasia, multifocal | |
MONDO:0859156 | dysostosis multiplex, Ain-Naz type | |
MONDO:0859166 | visceral leiomyopathy, African degenerative | |
MONDO:0859167 | hypokalemic tubulopathy and deafness | |
MONDO:0859170 | retinal dystrophy and microvillus inclusion disease | |
MONDO:0859172 | hemolytic disease of fetus and newborn, RH-induced | |
MONDO:0859184 | ventriculomegaly and arthrogryposis | |
MONDO:0859192 | cerebral cavernous malformation 4 | |
MONDO:0859203 | rhizomelic dysplasia, Ain-Naz type | |
MONDO:0859205 | delayed puberty, self-limited | |
MONDO:0859213 | congenital heart defects, multiple types, 8, with or without heterotaxy | |
MONDO:0859222 | heterotaxy, visceral, 12, autosomal | |
MONDO:0859226 | craniotubular dysplasia, Ikegawa type | |
MONDO:0859231 | macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin | |
MONDO:0859233 | epidermolysis bullosa, junctional 6, with pyloric atresia | |
MONDO:0859238 | hypoalphalipoproteinemia, primary, 2, intermediate | |
MONDO:0859246 | leukodystrophy, childhood-onset, remitting | |
MONDO:0859248 | corneal dystrophy, punctiform and polychromatic pre-descemet | |
MONDO:0859254 | hepatorenocardiac degenerative fibrosis | |
MONDO:0859264 | congenital myopathy 11 | |
MONDO:0859271 | glycosylphosphatidylinositol biosynthesis defect 25 | |
MONDO:0859273 | liver disease, severe congenital | |
MONDO:0859281 | intellectual developmental disorder with autism and dysmorphic facies | |
MONDO:0859289 | intestinal dysmotility syndrome | |
MONDO:0859290 | familial apolipoprotein gene cluster deletion syndrome | |
MONDO:0859302 | hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 | |
MONDO:0859307 | cleidocranial dysplasia 2 | |
MONDO:0859322 | myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis | |
MONDO:0859335 | congenital myopathy 15 | |
MONDO:0859336 | muscular dystrophy, congenital, with or without seizures | |
MONDO:0859355 | inflammatory poikiloderma with hair abnormalities and acral keratoses | |
MONDO:0859370 | respiratory infections, recurrent, and failure to thrive with or without diarrhea | |
MONDO:0859514 | congenital myopathy 18 | |
MONDO:0859515 | congenital myopathy 10b, mild variant | |
MONDO:0859517 | congenital myopathy 2b, severe infantile, autosomal recessive | |
MONDO:0859518 | leukodystrophy, hypomyelinating, 26, with chondrodysplasia | |
MONDO:0859523 | congenital myopathy 2c, severe infantile, autosomal dominant | |
MONDO:0859526 | immunodeficiency 109 with lymphoproliferation | |
MONDO:0859532 | congenital heart defects, multiple types, 9 | |
MONDO:0859564 | epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features | |
MONDO:0859565 | atrioventricular septal defect | |
MONDO:0859567 | craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 2 | |
MONDO:0859568 | macular dystrophy, retinal, 4 | |
MONDO:0859569 | braddock-carey syndrome 1 | |
MONDO:0859570 | braddock-carey syndrome 2 | |
MONDO:0859571 | diaphragmatic hernia 4, with cardiovascular defects | |
MONDO:0859572 | cardiac valvular dysplasia 2 | |
MONDO:0859573 | bent bone dysplasia syndrome 2 | |
MONDO:0859574 | ichthyosis, annular epidermolytic, 2 | |
MONDO:0859575 | Atelis syndrome 1 | |
MONDO:0859576 | Atelis syndrome 2 | |
MONDO:0859577 | lacrimoauriculodentodigital syndrome 2 | |
MONDO:0859578 | lacrimoauriculodentodigital syndrome 3 | |
MONDO:0859692 | immune-mediated cerebellar ataxia |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0005363 | inherited focal segmental glomerulosclerosis | focal segmental glomerulosclerosis | inherited focal segmental glomerulosclerosis |
MONDO:0007340 | cleidocranial dysplasia 1 | cleidocranial dysplasia | cleidocranial dysplasia 1 |
MONDO:0007777 | hypotaurinemic retinal degeneration and cardiomyopathy | hypertaurinuric cardiomyopathy | hypotaurinemic retinal degeneration and cardiomyopathy |
MONDO:0007788 | hypertriglyceridemia 1 | hypertriglyceridemia, familial | hypertriglyceridemia 1 |
MONDO:0007818 | hyper-IgE recurrent infection syndrome 1, autosomal dominant | hyper-IgE recurrent infection syndrome 1 | hyper-IgE recurrent infection syndrome 1, autosomal dominant |
MONDO:0800406 | ABCA4-related retinopathy | ABCA4 retinoapthy | ABCA4-related retinopathy |
MONDO:0009646 | monosomy 7 myelodysplasia and leukemia syndrome 1 | Monosomy 7 myelodysplasia and leukemia syndrome 1 | monosomy 7 myelodysplasia and leukemia syndrome 1 |
MONDO:0800407 | NYX-related retinopathy | NYX-related retinoapthy | NYX-related retinopathy |
MONDO:0020290 | familial atrioventricular septal defect | atrioventricular septal defect | familial atrioventricular septal defect |
MONDO:0015492 | anti-neutrophil cytoplasmic antibody-associated vasculitis | Anti-neutrophil cytoplasmic antibody-associated vasculitis | anti-neutrophil cytoplasmic antibody-associated vasculitis |
MONDO:0800402 | TRPM1-related retinopathy | TRPM1-related retinoapthy | TRPM1-related retinopathy |
MONDO:0013731 | MEGF10-related myopathy | MEGF10-Related Myopathy | MEGF10-related myopathy |
MONDO:0013815 | bent bone dysplasia syndr... |
v2023-04-04
Overview:
- Number of new terms: 278
- Number of changed labels: 31
- Number of changed definitions: 30
- Number obsoleted terms: 22
- Number of new obsoletion candidates: 14
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100217 | developmental delay with short stature, dysmorphic facial features, and sparse hair 2 | Any developmental delay with short stature, dysmorphic facial features, and sparse hair in which the cause of the disease is a mutation in the DPH2 gene. |
MONDO:0100256 | CTNNA1-related diffuse gastric and lobular breast cancer syndrome | Germline pathogenic or likely pathogenic variants in the CTNNA1 gene predispose to hereditary diffuse gastric cancer and lobular breast cancer, a cancer susceptibility syndrome inherited in an autosomal dominant pattern. |
MONDO:0100287 | POLE-related polyposis and colorectal cancer syndrome | An autosomal dominant hereditary syndrome caused by germline pathogenic POLE variants. It is characterized by the presence of colorectal polyps and colorectal cancer. |
MONDO:0100292 | Carey-Fineman-Ziter syndrome 2 | Any Carey-Fineman-Ziter syndrome in which the cause of the disease is a mutation in the MYMX gene. |
MONDO:0100293 | diaphragmatic malformation | |
MONDO:0100298 | abdominal wall malformation | |
MONDO:0100299 | PAX5-related B lymphopenia and autism spectrum disorder | PAX5 deficiency causing neurodevelopmental abnormalities including autism spectrum disorder in addition to hypogammaglobulinemia due to early B cell developmental block and impaired immune responses. |
MONDO:0100300 | hereditary capillary infantile hemangioma | An instance of capillary infantine hemangioma that is caused by an inherited genomic modification in an individual. |
MONDO:0100301 | hemangioma, capillary infantile, susceptibility to | An inherited susceptibility or predisposition to developing capillary infantile hemangioma. |
MONDO:0100302 | LADD syndrome 1 | Any LADD syndrome in which the cause of the disease is a variation in the FGFR2 gene. |
MONDO:0100303 | ichthyosis, annular epidermolytic 1 | Any annular epidermolytic ichthiosis in which the cause of the disease is a variation in the KRT10 gene. |
MONDO:0100517 | PSAP-related sphingolipidosis | A sphingolipidosis caused by variants in the PSAP gene. Clinical and biochemical features vary based on the location of variants within the gene and their molecular impact. |
MONDO:0100518 | hereditary attention deficit-hyperactivity disorder | An instance of attention deficit-hyperactivity disorder that is caused by an inherited genomic modification in an individual. |
MONDO:0700220 | disease related to transplantation | Disease that occurs as a consequence of immunosuppression in a recipient of a solid organ or bone marrow transplant, or as a consequence of the transplantation. |
MONDO:0700221 | disease related to solid organ transplantation | Disease that occurs as a consequence of immunosuppression in a recipient of a solid organ transplant, or as a consequence of the transplantation. |
MONDO:0700222 | disease related to hematopoietic stem cell transplant | Disease that occurs as a consequence of immunosuppression in a recipient of a hematopoietic stem cell transplant, or as a consequence of the transplantation. |
MONDO:0700223 | hereditary skeletal muscle disorder | An instance of muscle tissue disorder that is caused by an inherited genomic modification in an individual. |
MONDO:0700225 | hereditary gallbladder disorder | An instance of gallbladder disorder that is caused by an inherited genomic modification in an individual. |
MONDO:0700226 | food allergy | Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food. |
MONDO:0850092 | post-cardiac arrest syndrome | |
MONDO:0850093 | absence epilepsy | |
MONDO:0850101 | spitzoid melanoma | |
MONDO:0850110 | melanoma in congenital melanocytic nevus | |
MONDO:0850112 | breast implant-associated anaplastic large cell lymphoma | |
MONDO:0850125 | malignant adenoma | A cell type cancer that is composed of epithelial tissue in which tumor cells form glands or glandlike structures, representing an early form of colorectal cancer. |
MONDO:0850128 | epididymis disease | A male reproductive system disease that is located in the epididymis. |
MONDO:0850129 | gastroesophageal cancer | A gastrointestinal system cancer that is located in the proximal esophagus and the distal stomach. |
MONDO:0850130 | gastroesophageal adenocarcinoma | |
MONDO:0850149 | nephroma | A kidney benign neoplasm that is located in the kidney cortex. |
MONDO:0850151 | lymph node carcinoma | A lymph node cancer that has material basis in abnormally proliferating cells derives from epithelial cells. |
MONDO:0850152 | auditory system benign neoplasm | A sensory system benign neoplasm that is located in the auditory system. |
MONDO:0850154 | tongue carcinoma | |
MONDO:0850156 | B-lymphoblastic leukemia/lymphoma MLL rearranged | A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of a KMT2A related fusion protein. |
MONDO:0850157 | B-lymphoblastic leukemia/lymphoma with ETV6-RUNX1 | A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. |
MONDO:0850160 | B-lymphoblastic leukemia/lymphoma with IL3-IGH | A B-lymphoblastic leukemia/lymphoma that is characterized by the presence of lymphoblasts that carry a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). |
MONDO:0850161 | B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like | A B-lymphoblastic leukemia/lymphoma that has a gene expression profile similar to that of B-ALL with t(9;22)(q34.1;q11.2) BCR-ABL1, but lacks that gene fusion. |
MONDO:0850162 | B-lymphoblastic leukemia/lymphoma with IAMP21 | A B-lymphoblastic leukemia/lymphoma that is characterized by amplification of a portion of chromosome 21. |
MONDO:0850199 | NK cell deficiency | A primary immunodeficiency disease that results from defeciency in the number or function of CD56+CD3− NK cell in peripheral blood. |
MONDO:0850200 | T cell and NK cell immunodeficiency | A primary immunodeficiency disease that involves multiple components of the immune system, including both T cell and NK cell immunodeficiency. |
MONDO:0850201 | hereditary alpha tryptasemia syndrome | |
MONDO:0850223 | Libman-Sacks endocarditis | An endocarditis that is characterized by Libman-Sacks vegetations, is common in patients with systemic lupus erythematosus and is commonly complicated with embolic cerebrovascular disease. |
MONDO:0850273 | salivary gland mucinous adenocarcinoma | A salivary gland carcinoma that is characterized by the presence of large pools of extracellular mucin in which clusters of malignant epithelial cells are found. |
MONDO:0850281 | mammary analogue secretory carcinoma | A salivary gland carcinoma that has material basis in a chromosomal translocation that results in an ETV6-NTRK3 fusion gene. |
MONDO:0850292 | subjective cognitive decline | A cognitive disorder that is characterized by the presence of significant and persistent cognitive complaints. |
MONDO:0850295 | acquired laryngomalacia | A laryngeal disease that is characterized by acquired collapse of laryngeal suprastructures. |
MONDO:0850338 | spinal ependymoma, MYCN-amplified | A spinal cord ependymoma that is characterized by MYCN amplification. |
MONDO:0850345 | lung pleomorphic carcinoma | A pleomorphic carcinoma that is characterized by the presence of malignant glandular or squamous cells associated with malignant giant and spindle cells and that is located in the lung. |
MONDO:0850347 | bladder sarcomatoid transitional cell carcinoma | A sarcomatoid transitional cell carcinoma that is located in the bladder. |
MONDO:0850348 | bladder small cell carcinoma | A bladder carcinoma that is characterized as an undifferentiated neoplasm composed of primitive-appearing cells. |
MONDO:0850371 | nonobstructive coronary artery disease | A coronary artery disease that is characterized by atherosclerotic plaque that would not be expected to obstruct blood flow or result in anginal symptoms and stenosis of coronary artery less than 50 percent. |
MONDO:0850388 | childhood supratentorial embryonal tumor with multilayered rosettes, C19MC-altered | A childhood embryonal tumor with multilayered rosettes, C19MC-altered that arises from the supratentorial brain and occurs in children. |
MONDO:0850426 | high-grade B-cell lymphoma double-hit/triple-hit | A B-cell lymphoma that is characterized by the abnormal rearrangement of two genes, MYC gene and either BCL2 or BCL6 genes. |
MONDO:0850445 | benign peritoneal solitary fibrous tumor | A peritoneal benign neoplasm that is characterized by the presence of prominent hemangiopericytoma-like vessels. |
MONDO:0850459 | primary cutaneous gamma-delta t-cell lymphoma | A primary cutaneous T-cell non-Hodgkin lymphoma that is characterised by the clonal cutaneous proliferation of activated mature gamma-delta T cells with a cytotoxic phenotype. |
MONDO:0850461 | neurobehavioral disorder with prenatal alcohol exposure | A fetal alcohol spectrum disorder that is characterized by one or more deficits in neurocognition and in self-regulation plus two or more deficits in adaptive functioning, with at least 1 in communication or social communication and interaction. |
MONDO:0850514 | inclus... |
v2023-03-01
Overview:
- Number of new terms: 43
- Number of changed labels: 10
- Number of changed definitions: 37
- Number obsoleted terms: 14
- Number of new obsoletion candidates: 8
- Number of terms who were previously candidate for obsoletion and are now not anymore: 2
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100009 | structural congenital heart disease, multiple types - GATA4 | Any congenital heart disease in which the cause of the disease is a mutation in the GATA4 gene. |
MONDO:0100042 | cardiac conduction defect | |
MONDO:0100117 | obsolete familial sudden death | OBSOLETE. An instance of sudden cardiac death that is caused by an inherited genomic modification in an individual. |
MONDO:0100118 | genetic skin disorder | An instance of skin disease that is caused by a modification of the individual's genome. |
MONDO:0100167 | pulmonary disease, chronic obstructive, susceptibility to | An inherited susceptibility or predisposition to developing COPD. |
MONDO:0100295 | Alzheimer disease, susceptibility to, mitochondrial | |
MONDO:0100511 | sudden cardiac arrest | The sudden loss of all heart activity due to an irregular heart rhythm. |
MONDO:0700049 | infectious disease, non-human animal | Infectious disease that occurs in non-human animals. |
MONDO:0700050 | bacterial infectious disease, non-human animal | Bacterial infectious disease that occurs in non-human animals. |
MONDO:0700053 | viral infectious disease, non-human animal | Viral infectious disease that occurs in non-human animals. |
MONDO:0700056 | fungal infectious disease, non-human animal | Fungal infectious disease that occurs in non-human animals. |
MONDO:0700058 | Morton neuroma | Compressive neuropathy of the forefoot interdigital nerve chiefly due to compression and irritation at the plantar aspect of the transverse intermetatarsal ligament. It is not a true neuroma as the condition is degenerative rather than neoplastic. The most common location for Morton neuroma is between the 2nd and 3rd metatarsals. |
MONDO:0700059 | Actinobacillus infectious disease, non-human animal | Actinobacillus infectious disease that occurs in non-human animals. |
MONDO:0700072 | Rhabdoviridae infectious disease, non-human animal | Rhabdoviridae infectious disease that occurs in non-human animals. |
MONDO:0700095 | Reoviridae infectious disease, non-human animal | Reoviridae infectious disease that occurs in non-human animals. |
MONDO:0700113 | Anaplasmataceae infectious disease, non-human animal | Anaplasmataceae infectious disease that occurs in non-human animals. |
MONDO:0700114 | vector-borne disease, non-human animal | Vector-borne disease that occurs in non-human animals. |
MONDO:0700201 | tick-borne infectious disease, non-human animal | Tick-borne infectious disease that occurs in non-human animals. |
MONDO:0700202 | Bunyaviridae infectious disease, non-human animal | Bunyaviridae infectious disease that occurs in non-human animals. |
MONDO:0700203 | pestivirus infectious disease, non-human animal | Pestivirus infectious disease that occurs in non-human animals. |
MONDO:0700204 | trichostrongyloidiasis, non-human animal | Trichostrongyloidiasis that occurs in non-human animals. |
MONDO:0700205 | ehrlichiosis, non-human animal | Ehrlichiosis that occurs in non-human animals. |
MONDO:0700206 | Parvoviridae infectious disease, non-human animal | Parvoviridae infectious disease that occurs in non-human animals. |
MONDO:0700207 | constitutional delay of growth and puberty | Transient state of hypogonadotropic hypogonadism associated with prolongation of childhood phase of growth, delayed skeletal maturation, delayed and attenuated pubertal growth spurt, and relatively low insulin-like growth factor-1 secretion. |
MONDO:0700208 | Caliciviridae infectious disease, non-human animal | Caliciviridae infectious disease that occurs in non-human animals. |
MONDO:0700209 | Strongylida infectious disease, non-human animal | Strongylida infectious disease that occurs in non-human animals. |
MONDO:0700210 | enterovirus infectious disease, non-human animal | Enterovirus infectious disease that occurs in non-human animals. |
MONDO:0700211 | Erysipelothrix infectious disease, non-human animal | Erysipelothrix infectious disease that occurs in non-human animals. |
MONDO:0700212 | tuberculosis, non-human animal | Tuberculosis that occurs in non-human animals. |
MONDO:0700213 | trypanosomiasis, non-human animal | Trypanosomiasis that occurs in non-human animals. |
MONDO:0700214 | Herpesviridae infectious disease, non-human animal | Herpesviridae infectious disease that occurs in non-human animals. |
MONDO:0700215 | NTRK fusion positive cancer | Neoplasm defined by the expression of a Neurotrophic Tyrosine Receptor Kinase (NTRK) Fusion. NTRK fusion-positive tumors have been identified in a broad range of solid tumor types, including breast, cholangiocarcinoma, colorectal, gynecological, neuroendocrine, non-small cell lung, salivary gland, pancreatic, sarcoma and thyroid cancers. |
MONDO:0700216 | RET fusion positive cancer | Neoplasm defined by the expression of a RET (REarranged during Transfection) fusion. |
MONDO:0700217 | neonatal sepsis | Bacterial infection in the bloodstream of newborn infants younger than 28 days old. |
MONDO:0700218 | group B streptococcal infection | A disease caused by infection with Group B Streptococcus. |
MONDO:0700219 | neoplastic meningitis | Metastatic neoplasm in which the tumor cells spread to leptomeninges (pia and arachnoid) and subarachnoid space. The most common primary tumors metastasizing to the leptomeninges are breast and lung carcinomas, melanoma, aggressive non-Hodgkin lymphoma, and acute lymphocytic leukemia. |
MONDO:0850001 | congenital neuronal ceroid lipofuscinosis | Congenital neuronal ceroid lipofuscinosis (CNCL) is a severe form of neuronal ceroid lipofuscinosis (NCL; see this term) with onset at birth characterized by primary microcephaly, neonatal epilepsy, and death in early infancy. |
MONDO:0850008 | anterior segment developmental abnormality with extraocular manifestations | |
MONDO:0850009 | syndromic microspherophakia | |
MONDO:0850010 | congenital optic disc excavation | |
MONDO:0850013 | twin anemia-polycythemia sequence | |
MONDO:0850014 | twin-reversed arterial perfusion sequence | |
MONDO:0850015 | selective intrauterine growth restriction |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0000001 | disease | disease or disorder | disease |
MONDO:0003847 | hereditary disease | Mendelian disease | hereditary disease |
MONDO:0700096 | human disease | human disease or disorder | human disease |
MONDO:0007621 | Floating-Harbor syndrome | floating-Harbor syndrome | Floating-Harbor syndrome |
MONDO:0009263 | GAPO syndrome | gapo syndrome | GAPO syndrome |
MONDO:0009483 | Kapur-Toriello syndrome | kapur-Toriello syndrome | Kapur-Toriello syndrome |
MONDO:0009590 | metachromatic leukodystrophy due to saposin B deficiency | metachromatic leukodystrophy due to saposin b deficiency | metachromatic leukodystrophy due to saposin B deficiency |
MONDO:0011049 | Fine-Lubinsky syndrome | fine-Lubinsky syndrome | Fine-Lubinsky syndrome |
MONDO:0013166 | GABA aminotransaminase deficiency | GABA aminotransferase deficiency | GABA aminotransaminase deficiency |
MONDO:0015265 | bronchiolitis obliterans syndrome | bronchiolitis obliterans with obstructive pulmonary disease | bronchiolitis obliterans syndrome |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0005550 | infectious disease | A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. | A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent in humans. It can be transmitted by direct or indirect contact. |
MONDO:0007078 | pseudohypoparathyroidism type 1A | Pseudohypoparathyroidism type 1A (PHP1a) is a type of pseudohypoparathyroidism (PHP) characterized by renal resistance to parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, and elevated PTH; resistance to other hormones including thydroid stimulating hormone (TSH), gonadotropins and growth-hormone-releasing hormone (GHRH); and a constellation of clinical features known as Albright hereditary osteodystrophy (AHO). | A type of pseudohypoparathyroidism (PHP) characterized by renal resistance to parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, and elevated PTH; resistance to other hormones including thydroid stimulating hormone (TSH), gonadotropins and growth-hormone-releasing hormone (GHRH); and a constellation of clinical features known as Albright hereditary osteodystrophy (AHO). |
MONDO:0007412 | Beare-Stevenson cutis gyrata syndrome | Cutis Gyrata-Acanthosis nigricans-craniosynthosis also known as Beare-Stevenson syndrome (BSS) is a severe form of syndromic craniosynostosis, characterized by a variable degree of craniosynostosis, with cloverleaf skull reported in over 50% of cases, cutis gyrata, corduroy-like linear striations in the skin, acanthosis nigricans, skin tags, and choanal stenosis or atresia. Additional features include facial features similar to Crouzon disease, ear defects (conductive hearing loss, posteriorly angulated ears, stenotic auditory canals, preauricular furrows, and narrow ear canals), hirsutism, a prominent umbilical stump, and genitorurinary anomalies (anteriorly placed anus, hypoplasic labia, hypospadias). BSS is associated with a poor outcome as patients present an elevated risk for sudden death in their first year of life. Significant developmental delay an... |
v2023-02-06
Overview:
- Number of new terms: 17
- Number of changed labels: 11
- Number of changed definitions: 7
- Number obsoleted terms: 7
- Number of new obsoletion candidates: 22
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0031329 | craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome | |
MONDO:0031415 | Carey-Fineman-Ziter syndrome | |
MONDO:0031632 | developmental delay with short stature, dysmorphic facial features, and sparse hair | |
MONDO:0100158 | CHRNG-associated hypo-akinesia disorder of prenatal onset | A spectrum of presentations resulting from biallelic protein-altering variation in CHRNG. Inactivation of the receptor during early development leads to prenatal hypo-akinesia; subsequent phenotypes are a consequence of this hypo-akinesia and are thought to be dependent upon timing and severity of the anomaly at the neuromuscular junction. A range of phenotypes varying in severity (including both lethal and non-lethal presentations) have been reported, but typically include joint contractures, pterygia, dysmorphic features, vertebral and thoracic anomalies, and additional variable abnormalities. There are no clear genotype-phenotype correlations between the lethal and non-lethal presentations of this spectrum; both inter- and intra-familial variability have been reported, with the same variants being observed in both lethal and non-lethal cases. |
MONDO:0100190 | gastric intestinal metaplasia | Metaplastic changes in the lining of the upper digestive tract. |
MONDO:0100208 | self-limited familial neonatal-infantile epilepsy | An epilepsy syndrome associated with infantile period seizures, complete or nearly-complete seizure remission afterwards, usually good developmental outcome, and dominant transmission with high penetrance in pedigrees. For most affected infants, seizures begin within the first week after term birth. In a minority, however, seizures can begin after the first week but within the first several months of life. At onset, seizures may be highly recurrent, and often feature unilateral tonic limb stiffening that may alternate sides from seizure to seizure, accompanied by cyanosis and autonomic features. Limb shaking movements occur, but not in the evolving rhythmic pattern of tonic-clonic convulsions in older individuals. Neurological examination of the infant is normal between seizures. Although these seizures remit by 4-12 months of age in the majority, 15-30% of those affected have one or more seizure recurrences later, including febrile seizures, focal-onset seizures, and convulsions. Although most affected children show typical development, individuals with mild learning difficulties have been reported in families where the majority develop typically. |
MONDO:0100216 | DICER1-related tumor predisposition | Pathogenic germline variation in DICER1 confers an autosomal dominant predisposition to tumor formation at multiple primary sites, including pleuropulmonary blastoma, pulmonary cysts, thyroid gland neoplasia, ovarian tumors, and cystic nephroma. Other syndromic features such as macrocephaly have been described. |
MONDO:0100227 | ALS2-related motor neuron disease | Any motor neuron disease in which the cause of the disease is a mutation in the ALS2 gene. |
MONDO:0100235 | FOXC1-related anterior segment dysgenesis | Any anterior segment dysgenesis in which the cause of the disease is a mutation in the FOXC1 gene. |
MONDO:0100236 | LTBP2-related ocular dysgenesis | Any ocular dysgenesis disorder in which the cause of the disease is a mutation in the LTBP2 gene. |
MONDO:0100254 | CACNA1A-related complex neurodevelopmental disorder | A progressive complex neurodevelopmental condition caused by variants in the CACNA1A gene. Phenotypic onset (usually) occurs around age 1 and most often includes intellectual disability but can also include epileptic encephalopathy, benign paroxysmal torticollis of infancy and paroxysmal tonic upgaze psychomotor delay, learning difficulties, absence epilepsy, episodic ataxia, and hemiplegic migraines. |
MONDO:0700046 | baclofen withdrawal syndrome | Withdrawal syndrome involving the abrupt discontinuation of baclofen therapy (intrathecal or oral). Baclofen withdrawal syndrome can result in high fever, altered mental status (including agitation, insomnia, confusion, delusions, hallucinations, seizures, visual changes, or psychosis), and potentially profound muscular rigidity that sometimes progresses to fatal rhabdomyolysis. |
MONDO:0700047 | premenopausal osteoporosis | Osteoporosis occuring in premenopausal women with existing fragility fractures, diseases or treatments known to cause bone loss or fractures. |
MONDO:0700048 | hand-foot syndrome | A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents. |
MONDO:0800436 | craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 | Any craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development in which the cause of the disease is a variation in the TMCO1 gene. |
MONDO:0800437 | Carey-Fineman-Ziter syndrome 1 | A rare condition characterized by the association of hypotonia, Moebius sequence (bilateral congenital facial palsy with impairment of ocular abduction), Pierre-Robin sequence (micrognathia, glossoptosis, and high-arched or cleft palate), unusual face, and growth delay. |
MONDO:0800438 | developmental delay with short stature, dysmorphic facial features, and sparse hair 1 | Any developmental delay with short stature, dysmorphic facial features, and sparse hair in which the cause of the disease is a mutation in the DPH1 gene. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0013696 | chromosome 2p16.3 deletion syndrome | chromosome 2P16.3 deletion syndrome | chromosome 2p16.3 deletion syndrome |
MONDO:0021764 | acrofacial dysostosis Preis type | acrofacial dysostosis preis type | acrofacial dysostosis Preis type |
MONDO:0024773 | spermatogenic failure, X-linked, 4 | spermatogenic failure, x-linked, 4 | spermatogenic failure, X-linked, 4 |
MONDO:0025351 | multiple congenital anomalies-neurodevelopmental syndrome, X-linked | multiple congenital anomalies-neurodevelopmental syndrome, x-linked | multiple congenital anomalies-neurodevelopmental syndrome, X-linked |
MONDO:0035826 | symptomatic form of X-linked centronuclear myopathy in female carriers | symptomatic form of x-linked centronuclear myopathy in female carriers | symptomatic form of X-linked centronuclear myopathy in female carriers |
MONDO:0100024 | self-limited familial infantile epilepsy | self-limited familial and non-familial infantile seizures | self-limited familial infantile epilepsy |
MONDO:0800250 | Graves disease, susceptibility to, X-linked 2 | graves disease, susceptibility to, x-linked 2 | Graves disease, susceptibility to, X-linked 2 |
MONDO:0800318 | Emery-Deifuss muscular dystrophy 6, X-linked | Emery-dDeifuss muscular dystrophy 6, x-linked | Emery-Deifuss muscular dystrophy 6, X-linked |
MONDO:0800319 | cone dystrophy 5, X-linked | cone dystrophy 5, x-linked | cone dystrophy 5, X-linked |
MONDO:0800320 | cone dystrophy 1, X-linked | cone dystrophy 1, x-linked | cone dystrophy 1, X-linked |
MONDO:0800321 | congenital heart defects, multiple types, 1, X-linked | congenital heart defects, multiple types, 1, x-linked | congenital heart defects, multiple types, 1, X-linked |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0005567 | substance withdrawal syndrome | A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of an addictive substance, e.g. opioids, barbiturates and alcohol; amphetamines or similarly acting sympathomimetics; cocaine; nicotine; sedatives, hypnotics, or anxiolytics. Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. | A substance-specific organic brain syndrome that follows the discontinuation of administration or use, or reduction in intake of a substance (including alcohol, prescribed medications and recreational drugs). Syndrome manifests with diverse, often painful physical and psychological symptoms, which include but not limited to intense drug craving, anxiety, depression, insomnia, nausea, perspiration, body aches, tremors, hallucinations, and convulsions. |
MONDO:0005789 | hepatitis D virus infection | Inflammation of the liver in humans caused by hepatitis delta virus, a defective rna virus that can only infect hepatitis B patients. For its viral coating, hepatitis delta virus requires the hepatitis B surface antigens produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. | Inflammation of the liver in humans caused by hepatitis delta virus, a defective RNA virus that can only infect hepatitis B patients. For its viral coating, hepatitis delta virus requires the hepatitis B surface antigens produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily trans... |